Prosecution Insights
Last updated: April 19, 2026

Norton Rose Fulbright - Ut Southwestern

15 pending office actions • 3 clients

Portfolio Summary

15
Total Pending OAs
7
Final Rejections
8
Non-Final OAs

Client Portfolio (3 clients)

Client (Assignee)Pending OAs
The Board Of Regents Of The University Of Texas System 10
The Board Of Regents Of The University Of Texas System 4
The Board Of Regents Of The University Of Texas System 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18933931 IMAGING SYSTEM AND METHOD TO CONVERT LATERAL SCANNING INTO AXIAL REMOTE FOCUSING The Board Of Regents Of The University Of Texas System BOYLAN, JAMES T 2486 Non-Final OA Oct 31, 2024
18697643 OPTICAL ROTATOR SYSTEMS AND METHODS The Board Of Regents Of The University Of Texas System MUHAMMAD, KEY 2872 Non-Final OA Apr 01, 2024
18504868 METHODS OF PREDICTING AND TREATING IMMUNOTHERAPY TOXICITY BASED ON IMMUNE CELL POPULATIONS The Board Of Regents Of The University Of Texas System DAUNER, JOSEPH G 1682 Non-Final OA Nov 08, 2023
18266712 TAU BIOSENSOR CELL LINES The Board Of Regents Of The University Of Texas System WESTON, ALYSSA G 1633 Non-Final OA Jun 12, 2023
18177265 ENDORECTAL COOLING DEVICE HOLDER The Board Of Regents Of The University Of Texas System BORSCH, NICHOLAS S 3794 Final Rejection Mar 02, 2023
18014850 TDP-43 BIOSENSOR CELL LINES The Board Of Regents Of The University Of Texas System KASAYAN, KATRIEL BARCELLANO 1634 Non-Final OA Jan 06, 2023
18062937 PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY The Board Of Regents Of The University Of Texas System HALVORSON, MARK 1646 Non-Final OA Dec 07, 2022
17998037 SYSTEMS AND METHODS FOR CHARACTERIZING A TUMOR MICROENVIRONMENT USING PATHOLOGICAL IMAGES The Board Of Regents Of The University Of Texas System SHARIFF, MICHAEL ADAM 2672 Non-Final OA Nov 06, 2022
17905285 METHOD FOR DIAGNOSIS AND/OR PROGNOSIS OF LIVER DISEASE PROGRESSION AND RISK OF HEPATOCELLULAR CARCINOMA AND DISCOVERY OF THERAPEUTIC COMPOUNDS AND TARGETS TO TREAT LIVER DISEASE AND CANCER The Board Of Regents Of The University Of Texas System HUDSON, AMY ROSE 1636 Non-Final OA Aug 30, 2022
17782402 URINE ANALYSIS DEVICES AND METHODS FOR REAL TIME MONITORING OF KIDNEY FUNCTION The Board Of Regents Of The University Of Texas System WESTFALL, SARAH ANN 3791 Final Rejection Jun 03, 2022
17684639 METHODS AND COMPOSITIONS FOR DETECTING PROTEIN TARGETS The Board Of Regents Of The University Of Texas System SVEIVEN, MICHAEL CAMERON 1678 Final Rejection Mar 02, 2022
17753038 PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY The Board Of Regents Of The University Of Texas System COX, THADDEUS B 3791 Final Rejection Feb 16, 2022
17265333 ADJUVANT EFFECT OF THE TLR1/2 AGONIST DIPROVOCIM SYNERGIZES WITH CHECKPOINT-INHIBITING ANTIBODIES TO ELIMINATE DISEASE The Board Of Regents Of The University Of Texas System BRAUN, MADELINE E 1624 Final Rejection Feb 02, 2021
17153128 PET RADIOPHARMACEUTICALS FOR NON-INVASIVE EVALUATION OF HIF-2alpha The Board Of Regents Of The University Of Texas System LU, CHENG 1642 Final Rejection Jan 20, 2021
17129352 PET RADIOPHARMACEUTICALS FOR NON-INVASIVE EVALUATION OF HIF-2alpha The Board Of Regents Of The University Of Texas System LU, CHENG 1642 Final Rejection Dec 21, 2020

Managing Norton Rose Fulbright - Ut Southwestern's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month